Table 2.
Trust, Patient–Provider Interaction Quality, and HIV Care and Outcomes, by Patient Race
| |
Patient race |
|
|
|---|---|---|---|
| African American (n = 2,618 visits) | White (n = 412 visits) | p Valuea | |
| Trust (0–10 scale), mean (SD)a | 8.9 (2.2) | 9.4 (1.5) | <0.001 |
| Interaction quality (1–4 scale), mean (SD) | 3.85 (0.42) | 3.86 (0.36) | 0.21 |
| Receiving ART,bn (%) | 1,816 (85) | 323 (92) | 0.02 |
| Complete 3-day adherence,cn (%) | 1,512 (83) | 287 (89) | 0.005 |
| Suppressed viral load,bn (%) | 851 (40) | 164 (47) | 0.04 |
ART, antiretroviral therapy.
a
The p values represent a comparison of African Americans and whites, by using generalized estimating equation models, adjusting for age, sex, sexual preference, history of injection-drug use, and overall quality of life.
b
Among patients receiving antiretroviral treatment or with CD4 count ≤350 cells/mm3.
c
Among patients receiving antiretroviral treatment.